Radiolabeled Study to Determine the Mass Balance of [14C] MGL-3196
NCT03220165
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
8
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
MGL-3196
Sponsor
Madrigal Pharmaceuticals, Inc.
Collaborators
[object Object]